arrow
Return

Crystal Polymorphism in Chemical Process Development

delete2011-07-15
delete377
PRE
AI
A
Alfred Y. Lee *
D
Deniz Erdemir
A
Allan S. Myerson
DOI:10.1146/annurev-chembioeng-061010-114224delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Polymorphism in molecular crystals is a prevalent phenomenon and is of great interest to the pharmaceutical community. The solid-state form is a key quality attribute of a crystalline product. Inconsistencies in the solid phase produced during the manufacturing and storage of drug substances and drug products may have severe consequences. It is essential to understand the solid-state behavior of the drug and to judiciously select the optimal solid form for development. This review highlights the pervasiveness and relevance of polymorphism and describes solid form screening and selection processes. Moreover, case studies on controlling polymorphs from a chemical development perspective are provided.
Keywords:
crystallization process development
nucleation
crystal growth
polymorph screening
phase transformation
structure-property relationship
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Annual Review of Chemical and Biomolecular Engineering cover
Annual Review of Chemical and Biomolecular Engineering
IF:
12.8
Papers:
286
Citations:
3.0K

Organization

B
bristol-myers squibb
Scholars:
1.2W
Papers: 5.7K
Citations: 18
M
merck & company usa
Scholars:
6.3K
Papers: 3.5K
Citations: 5
M
merck & company
Scholars:
1.8W
Papers: 8.7K
Citations: 11
researcher View more organizations